New weekly injection aims to shield vulnerable immune patients from dangerous infections
Disease control
Recruiting now
This study is testing a new weekly injection of immune proteins (immunoglobulins) for people with primary immunodeficiency, a condition where the body's natural defense system doesn't work properly. The main goal is to see if this new treatment is safe, well-tolerated, and can ef…
Phase: PHASE3 • Sponsor: Biopharma Plasma LLC • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC